SI2575802T1 - Fosfaplatini in njihova uporaba za zdravljenje raznih vrst raka - Google Patents

Fosfaplatini in njihova uporaba za zdravljenje raznih vrst raka

Info

Publication number
SI2575802T1
SI2575802T1 SI201131103A SI201131103A SI2575802T1 SI 2575802 T1 SI2575802 T1 SI 2575802T1 SI 201131103 A SI201131103 A SI 201131103A SI 201131103 A SI201131103 A SI 201131103A SI 2575802 T1 SI2575802 T1 SI 2575802T1
Authority
SI
Slovenia
Prior art keywords
phosphaplatins
cancers
treatment
Prior art date
Application number
SI201131103A
Other languages
English (en)
Inventor
Rathindra N. Bose
Original Assignee
Ohio University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44627266&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2575802(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ohio University filed Critical Ohio University
Publication of SI2575802T1 publication Critical patent/SI2575802T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/245Bismuth; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI201131103A 2010-06-04 2011-06-02 Fosfaplatini in njihova uporaba za zdravljenje raznih vrst raka SI2575802T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35151410P 2010-06-04 2010-06-04
PCT/US2011/038948 WO2011153365A1 (en) 2010-06-04 2011-06-02 Phosphaplatins and their use for treatment of cancers
EP11726567.8A EP2575802B1 (en) 2010-06-04 2011-06-02 Phosphaplatins and their use for treatment of cancers

Publications (1)

Publication Number Publication Date
SI2575802T1 true SI2575802T1 (sl) 2017-03-31

Family

ID=44627266

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201131103A SI2575802T1 (sl) 2010-06-04 2011-06-02 Fosfaplatini in njihova uporaba za zdravljenje raznih vrst raka

Country Status (30)

Country Link
US (4) US9688709B2 (sl)
EP (1) EP2575802B1 (sl)
JP (1) JP5860872B2 (sl)
KR (1) KR101775410B1 (sl)
CN (6) CN103037859A (sl)
AP (1) AP3480A (sl)
AU (1) AU2011261381B2 (sl)
BR (1) BR112012030927B1 (sl)
CA (1) CA2800898C (sl)
CL (1) CL2012003416A1 (sl)
CO (1) CO6640302A2 (sl)
CY (1) CY1118466T1 (sl)
DK (1) DK2575802T3 (sl)
EA (1) EA021526B1 (sl)
ES (1) ES2606855T3 (sl)
HR (1) HRP20170225T1 (sl)
HU (1) HUE030249T2 (sl)
IL (1) IL223405B (sl)
LT (1) LT2575802T (sl)
MX (1) MX2012014174A (sl)
MY (1) MY162902A (sl)
NZ (1) NZ603952A (sl)
PL (1) PL2575802T3 (sl)
PT (1) PT2575802T (sl)
RS (1) RS55714B1 (sl)
SG (1) SG185722A1 (sl)
SI (1) SI2575802T1 (sl)
SM (1) SMT201700056B (sl)
WO (1) WO2011153365A1 (sl)
ZA (1) ZA201209007B (sl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103037859A (zh) 2010-06-04 2013-04-10 俄亥俄大学 磷铂及其在治疗癌症中的用途
EP2663301A1 (en) * 2011-01-12 2013-11-20 Ohio University Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
MX357865B (es) * 2011-10-05 2018-07-25 N Bose Rathindra Procedimientos eficientes para preparación a gran escala de agentes antitumorales de fosfaplatinos.
CN104010508B (zh) * 2011-10-05 2017-03-15 理辛德拉·N·博斯 用于大规模制备磷铂类抗肿瘤剂的高效方法
HUE046327T2 (hu) * 2012-05-24 2020-03-30 Phosplatin Therapeutics Llc Tisztítási eljárás foszfaplatin vegyületekhez
JP6382231B2 (ja) * 2013-02-22 2018-08-29 ユニバーシティ オブ ヒューストンUniversity Of Houston 神経保護剤としてのホスファプラチン
EP3107534A4 (en) * 2014-02-19 2017-09-06 The University Of Houston System Compositions and methods for the treatment of neurodegenerative diseases
KR102419247B1 (ko) * 2016-04-06 2022-07-11 포스플라틴 테라퓨틱스 인코포레이티드 포스파플라틴 액제 제형
CN110381952B (zh) * 2017-01-06 2023-10-20 弗斯普拉廷治疗有限公司 作为治疗剂用于治疗骨癌或血癌的磷铂化合物
CA3074020A1 (en) * 2017-09-08 2019-03-14 Phosplatin Therapeutics Llc Phosphaplatin compounds as immuno-modulatory agents and therapeutic uses thereof
JP2023547835A (ja) * 2020-10-20 2023-11-14 プロモントリー・セラピューティクス・インコーポレイテッド 高解糖性腫瘍細胞を選択的に標的化する治療剤としてのホスファプラチン化合物及びその方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4234500A (en) 1979-03-07 1980-11-18 Engelhard Minerals & Chemicals Corporation Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
US4291027A (en) 1979-03-07 1981-09-22 Engelhard Minerals & Chemicals Corp. Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
CA2017739A1 (en) 1989-07-18 1991-01-18 Leslie S. Hollis Cis-diamineplatinum complexes with methanediphosphonate and substituted methanediphosphonate ligands as antitumor agents
AUPR330201A0 (en) * 2001-02-23 2001-03-22 University Of Sydney, The Metal complexes and therapeutic uses thereof
DE10314780A1 (de) 2003-03-19 2004-09-30 Ktb Tumorforschungsgesellschaft Mbh Proteinbindende Derivate von Platinkomplexen mit Cyclobutan-1,1-dicarboxylatliganden
WO2004098524A2 (en) * 2003-05-02 2004-11-18 Aronex Pharmaceuticals, Inc. Lipid platinum complexes and methods of use thereof
JP4463274B2 (ja) 2003-06-27 2010-05-19 明 小谷 ビスホスホネート錯体
EP2177525A1 (en) 2007-07-06 2010-04-21 TMRC Co., Ltd. Metal complex compound, cancer therapeutic composition comprising the metal complex compound as active ingredient, and intermediate for production of the metal complex compound
EP2668949A1 (en) * 2007-08-06 2013-12-04 Ohio University Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
JP5553275B2 (ja) * 2010-03-31 2014-07-16 国立大学法人金沢大学 金属錯体およびこれを有効成分として含有する抗がん剤
CN103037859A (zh) 2010-06-04 2013-04-10 俄亥俄大学 磷铂及其在治疗癌症中的用途
EP2663301A1 (en) * 2011-01-12 2013-11-20 Ohio University Phosphaplatins having anti-angiogenic, anti-metastatic, and pro-apoptotic properties and uses thereof
MX357865B (es) * 2011-10-05 2018-07-25 N Bose Rathindra Procedimientos eficientes para preparación a gran escala de agentes antitumorales de fosfaplatinos.

Also Published As

Publication number Publication date
DK2575802T3 (en) 2017-01-09
KR20130095244A (ko) 2013-08-27
US20170327522A1 (en) 2017-11-16
ES2606855T3 (es) 2017-03-28
US20170327521A1 (en) 2017-11-16
CA2800898C (en) 2018-12-04
JP2013529219A (ja) 2013-07-18
HUE030249T2 (en) 2017-04-28
AU2011261381B2 (en) 2015-04-02
CO6640302A2 (es) 2013-03-22
CN108409795A (zh) 2018-08-17
CN108210516A (zh) 2018-06-29
SMT201700056B (it) 2017-03-08
AP3480A (en) 2015-12-31
KR101775410B1 (ko) 2017-09-06
EA021526B1 (ru) 2015-07-30
EP2575802A1 (en) 2013-04-10
HRP20170225T1 (hr) 2017-04-07
CY1118466T1 (el) 2017-07-12
ZA201209007B (en) 2013-08-28
JP5860872B2 (ja) 2016-02-16
CN108392490A (zh) 2018-08-14
BR112012030927A2 (pt) 2017-12-05
WO2011153365A1 (en) 2011-12-08
US9688709B2 (en) 2017-06-27
CL2012003416A1 (es) 2013-09-06
US20190315789A1 (en) 2019-10-17
IL223405B (en) 2018-11-29
CA2800898A1 (en) 2011-12-08
EA201270812A1 (ru) 2013-05-30
BR112012030927B1 (pt) 2021-09-21
SG185722A1 (en) 2013-01-30
MX2012014174A (es) 2013-07-03
PT2575802T (pt) 2016-12-27
US10364264B2 (en) 2019-07-30
PL2575802T3 (pl) 2017-04-28
MY162902A (en) 2017-07-31
AU2011261381A1 (en) 2013-01-10
CN108299508A (zh) 2018-07-20
US10759820B2 (en) 2020-09-01
NZ603952A (en) 2014-07-25
US20130064902A1 (en) 2013-03-14
AP2012006594A0 (en) 2012-12-31
CN108186651A (zh) 2018-06-22
EP2575802B1 (en) 2016-11-16
RS55714B1 (sr) 2017-07-31
US10385083B2 (en) 2019-08-20
CN103037859A (zh) 2013-04-10
LT2575802T (lt) 2016-12-27

Similar Documents

Publication Publication Date Title
IL276362A (en) Cancer treatment methods
IL248530A0 (en) Biomarkers and treatment methods
HRP20170225T1 (hr) Fosfoplatini i njihova uporaba za liječenje karcinoma
HRP20171352T1 (hr) Wnt-antagonisti i postupci liječenja
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
SG10201508495VA (en) Combination treatment of cancer
IL222227A0 (en) Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use
EP2539005A4 (en) ORAL PIECE AND METHODS OF USING THE SAME
ZA201300218B (en) Treatment of blood cancer
HK1189272A1 (zh) 治療癌症的方法
EP2574172A4 (en) MATERIALS AND METHOD FOR TREATING INFLAMMATION
IL256026B (en) Treatment methods
EP2640390A4 (en) METHODS OF TREATING CANCER
EP2547368A4 (en) METHOD AND COMPOSITIONS FOR CANCER TREATMENT
EP2709730A4 (en) TREATMENT AND PROGNOSIS OF CANCER
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
EP2574194A4 (en) MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT
GB201017354D0 (en) Treatment of cancer
GB201017356D0 (en) Combination treatment of cancer
GB201002499D0 (en) Treatment of tumours
HUP1000688A2 (en) Use of trifluoro-phthalimides in the treatment of cancer
ZA201301175B (en) Biomarkers and methods of treatment